{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:53:50Z","timestamp":1793836430183,"version":"4.6.1"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001427","name":"All India Council for Technical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001427","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016045","name":"University of Central Punjab","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118205","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T08:51:44Z","timestamp":1759308704000},"page":"118205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Design, synthesis, anticancer evaluation, and In silico studies of 2-thiopyrimidine-5-carbonitrile derivatives as potent thymidylate synthase inhibitors"],"prefix":"10.1016","volume":"301","author":[{"given":"Aashish","family":"Jaitak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash","family":"Jangid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajveer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4004-6241","authenticated-orcid":false,"given":"Vikramdeep","family":"Monga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118205_bib1","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3390\/cancers16101878","article-title":"Historical perspective and current trends in anticancer drug development","volume":"16","author":"Gach-Janczak","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2025.118205_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211034366","article-title":"New approaches and procedures for cancer treatment: current perspectives","volume":"9","author":"Debela","year":"2021","journal-title":"SAGE Open Med."},{"key":"10.1016\/j.ejmech.2025.118205_bib3","first-page":"10","article-title":"Pyrimidine as anticancer agent: a review","volume":"2","author":"Dudhe","year":"2011","journal-title":"J. Adv. Sci. Res."},{"key":"10.1016\/j.ejmech.2025.118205_bib4","first-page":"223","article-title":"New nucleoside analogs in the treatment of hematological disorders, acta pol","volume":"61","author":"Szafraniec","year":"2004","journal-title":"Pharm. Times"},{"key":"10.1016\/j.ejmech.2025.118205_bib5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.118205_bib6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/oxfordjournals.annonc.a059353","article-title":"Folate-based thymidylate synthase inhibitors as anticancer drugs","volume":"6","author":"Jackman","year":"1995","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejmech.2025.118205_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1535-6108(04)00080-7","article-title":"Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme","volume":"5","author":"Rahman","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2025.118205_bib8","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1007\/s00210-024-03020-y","article-title":"An insight into thymidylate synthase inhibitor as anticancer agents: an explicative review","volume":"397","author":"Sen","year":"2024","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ejmech.2025.118205_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.uct.2006.09.001","article-title":"Thymidylate synthase inhibitors","volume":"1","author":"Ackland","year":"2006","journal-title":"Update Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2025.118205_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.118205_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.mam.2016.11.005","article-title":"Targeting nuclear thymidylate biosynthesis","volume":"53","author":"Chon","year":"2017","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.ejmech.2025.118205_bib12","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.3_suppl.93","article-title":"A phase Ib study of NUC-3373 in combination with standard therapies in advanced\/metastatic colorectal cancer (NuTide: 302)","author":"Coveler","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118205_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00280-023-04528-5","article-title":"The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-Damaging agent","volume":"91","author":"Br\u00e9","year":"2023","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118205_bib14","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.3_suppl.93","article-title":"A phase Ib study of NUC-3373 in combination with standard therapies in advanced\/metastatic colorectal cancer (NuTide: 302)","author":"Coveler","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118205_bib15","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1016\/j.bmcl.2014.07.049","article-title":"Structural studies provide clues for analog design of specific inhibitors of Cryptosporidium hominis thymidylate synthase\u2013dihydrofolate reductase","volume":"24","author":"Kumar","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118205_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cllc.2017.06.013","article-title":"A review of regimens combining pemetrexed with an epidermal growth factor receptor tyrosine kinase inhibitor in the treatment of advanced nonsquamous non\u2013small-cell lung cancer","volume":"19","author":"Yang","year":"2018","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.ejmech.2025.118205_bib17","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1021\/jm901869w","article-title":"Novel approaches for targeting thymidylate synthase to overcome the resistance and toxicity of anticancer drugs","volume":"53","author":"Garg","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib18","doi-asserted-by":"crossref","first-page":"8977","DOI":"10.1073\/pnas.88.20.8977","article-title":"Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase","volume":"88","author":"Chu","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2025.118205_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/07391102.2007.10507174","article-title":"Fluorescence spectroscopic and 19F NMR studies of human thymidylate synthase with its cognate RNA","volume":"25","author":"Hasnat","year":"2007","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2025.118205_bib20","first-page":"1116","article-title":"LY231514, a pyrrolo [2, 3-d] pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes","volume":"57","author":"Shih","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118205_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0006-2952(03)00287-9","article-title":"Induction of resistance to the multitargeted antifolate pemetrexed (ALIMTA) in WiDr human Colon cancer cells is associated with thymidylate synthase overexpression","volume":"66","author":"Sigmond","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118205_bib22","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1200\/JCO.1998.16.3.1131","article-title":"Preclinical and phase I clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumors","volume":"16","author":"Rafi","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118205_bib23","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2010.28.15_suppl.e21007","article-title":"Mechanism of chemoresistance to 5-fluorouracil mediated by miR-192\/miR-215 in colon cancer cell lines: Cell-cycle effects and post-transcriptional thymidilate synthase regulation","volume":"28","author":"Boni","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118205_bib24","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2174\/0929867054864868","article-title":"Thymidylate synthase structure, function and implication in drug discovery","volume":"12","author":"Costi","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib25","doi-asserted-by":"crossref","first-page":"11959","DOI":"10.1080\/21655979.2021.2009422","article-title":"MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase)","volume":"12","author":"Wan","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.ejmech.2025.118205_bib26","first-page":"1043","article-title":"Synthesis and antimicrobial activity of new amino derivatives of pyrano [4\u2019\u2019, 3\u2019\u2019: 4\u2019, 5\u2019] pyrido [3\u2019, 2\u2019: 4, 5] thieno [3, 2-d] pyrimidine, An. Acad. Bras","volume":"90","author":"Sirakanyan","year":"2018","journal-title":"Cienc."},{"key":"10.1016\/j.ejmech.2025.118205_bib27","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.4155\/fmc-2019-0050","article-title":"Synthesis and anticancer activity of some pyrido [2, 3-d] pyrimidine derivatives as apoptosis inducers and cyclin-dependent kinase inhibitors","volume":"11","author":"Abbas","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib28","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1039\/D0RA10657G","article-title":"Research developments in the syntheses, anti-inflammatory activities and structure\u2013activity relationships of pyrimidines","volume":"11","author":"ur Rashid","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.118205_bib29","article-title":"Synthesis, characterization, docking study and biological evaluation of new chalcone, pyrazoline, and pyrimidine derivatives as potent antimalarial compounds","volume":"14","author":"Alidmat","year":"2021","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91473-z","article-title":"Design, synthesis, molecular docking, and in vitro \u03b1-glucosidase inhibitory activities of novel 3-amino-2, 4-diarylbenzo [4, 5] imidazo [1, 2-a] pyrimidines against yeast and rat \u03b1-glucosidase","volume":"11","author":"Peytam","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118205_bib31","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.3390\/molecules24091718","article-title":"Pyrimidine 2, 4-diones in the design of new HIV RT inhibitors","volume":"24","author":"Romeo","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118205_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2298\/JSC170127109U","article-title":"Synthesis, characterization and anthelmintic activity evaluation of pyrimidine derivatives bearing carboxamide and sulphonamide moieties","volume":"83","author":"Ugwu","year":"2018","journal-title":"J. Serb. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118205_bib33","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.3390\/molecules26082370","article-title":"Promising antidiabetic and antimicrobial agents based on fused pyrimidine derivatives: molecular modeling and biological evaluation with histopathological effect","volume":"26","author":"Bassyouni","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118205_bib34","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.3390\/molecules23112913","article-title":"Design, synthesis, molecular modeling, and biological evaluation of novel thiouracil derivatives as potential antithyroid agents","volume":"23","author":"Awad","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118205_bib35","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1039\/D3RA00056G","article-title":"Medicinal chemistry perspective of pyrido [2, 3-d] pyrimidines as anticancer agents","volume":"13","author":"Kumar","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.118205_bib36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/00397911.2016.1165254","article-title":"Synthetic chemistry of pyrimidines and fused pyrimidines: a review","volume":"46","author":"Mohana Roopan","year":"2016","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2025.118205_bib37","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2174\/1389557516666160923125801","article-title":"Roles of pyridine and pyrimidine derivatives as privileged scaffolds in anticancer agents","volume":"17","author":"Prachayasittikul","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib38","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ejmech.2014.10.008","article-title":"In search of uracil derivatives as bioactive agents. Uracils and fused uracils: synthesis, biological activity and applications","volume":"97","author":"Pa\u0142asz","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137435","article-title":"Novel uracil derivatives as anti-cancer agents: design, synthesis, biological evaluation and computational studies","volume":"1302","author":"Baziyar","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118205_bib40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejmech.2019.03.047","article-title":"Design, synthesis and biological evaluation of novel uracil derivatives bearing 1, 2, 3-triazole moiety as thymidylate synthase (TS) inhibitors and as potential antitumor drugs","volume":"171","author":"Lu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jare.2020.07.008","article-title":"Development of a novel thymidylate synthase (TS) inhibitor capable of up-regulating P53 expression and inhibiting angiogenesis in NSCLC","volume":"26","author":"Li","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejmech.2025.118205_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115600","article-title":"Discovery of novel thymidylate synthase (TS) inhibitors that influence cancer angiogenesis and metabolic reprogramming in NSCLC cells","volume":"258","author":"Dong","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108066","article-title":"Rational design, synthesis, biological evaluation, molecular docking, and molecular dynamics of substituted uracil derivatives as potent anti-cancer agents","volume":"154","author":"Basiony","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib44","article-title":"Exploring cyclopropylamine containing cyanopyrimidines as LSD1 inhibitors: design, synthesis, ADMET, MD analysis and anticancer activity profiling","volume":"147","author":"Sheikh","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib45","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/molecules21080894","article-title":"Ultrasound mediated One-Pot, three component synthesis, docking and ADME prediction of novel 5-Amino-2-(4-chlorophenyl)-7-Substituted Phenyl-8, 8a-dihydro-7 H-(1, 3, 4) thiadiazolo (3, 2-\u03b1) pyrimidine-6-carbonitrile derivatives as anticancer agents","volume":"21","author":"Tiwari","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118205_bib46","first-page":"102","article-title":"Design, synthesis, molecular docking of new thiopyrimidine-5-carbonitrile derivatives and their cytotoxic activity against HepG2 cell line","volume":"4","author":"Eweas","year":"2014","journal-title":"J. Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2025.118205_bib47","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1080\/00397911.2017.1332223","article-title":"Design, synthesis of new pyrimidine derivatives as anticancer and antimicrobial agents","volume":"47","author":"Mohamed","year":"2017","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2025.118205_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103159","article-title":"Design, synthesis, anticancer evaluation and docking studies of new pyrimidine derivatives as potent thymidylate synthase inhibitors","volume":"91","author":"Amin","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib49","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s11030-017-9776-1","article-title":"Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents","volume":"21","author":"El-Naggar","year":"2017","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2025.118205_bib50","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00044-022-02950-7","article-title":"Synthesis and in vitro antitumor activity evaluation of novel 5-cyano-6-phenyl-2, 4-disubstituted-pyrimidine derivatives","volume":"31","author":"Si","year":"2022","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.118205_bib51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/ardp.200800223","article-title":"Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents","volume":"342","author":"Rostom","year":"2009","journal-title":"Arch. Pharm. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900333","article-title":"Methylene\u2010bearing sulfur\u2010containing cyanopyrimidine derivatives for treatment of cancer: part-ii","volume":"353","author":"Akhtar","year":"2020","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.118205_bib53","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1016\/j.bmcl.2007.09.047","article-title":"Novel scaffold for cathepsin K inhibitors","volume":"17","author":"Teno","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118205_bib54","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrc3916","article-title":"Replication stress and cancer","volume":"15","author":"Gaillard","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.118205_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2020.129695","article-title":"Combinatorial therapy of Thymoquinone and Emodin synergistically enhances apoptosis, attenuates cell migration and reduces stemness efficiently in breast cancer","volume":"1864","author":"Bhattacharjee","year":"2020","journal-title":"BBA - General Subjects"},{"key":"10.1016\/j.ejmech.2025.118205_bib56","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.3390\/cancers12092505","article-title":"The inducible role of ambient particulate matter in cancer progression via oxidative stress-mediated reactive oxygen species pathways: a recent perception","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2025.118205_bib57","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1200\/JCO.1997.15.5.1923","article-title":"Prognostic importance of thymidylate synthase expression in early breast cancer","volume":"15","author":"Pestalozzi","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118205_bib58","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ijc.11014","article-title":"New prognostic indicator for non\u2010small\u2010cell lung cancer, quantitation of thymidylate synthase by real\u2010time reverse transcription polymerase chain reaction","volume":"104","author":"Shintani","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2025.118205_bib59","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1634\/theoncologist.2010-0224","article-title":"Approval summary: pemetrexed maintenance therapy of advanced\/metastatic nonsquamous, non-small cell lung cancer (NSCLC)","volume":"15","author":"Cohen","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.ejmech.2025.118205_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219469","article-title":"High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinoma","volume":"14","author":"Donner","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118205_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142053","article-title":"Synthesis and anticancer evaluation of novel pyrrole-pyrido [2, 3-d] pyrimidine-based compounds as thymidylate synthase inhibitors","volume":"1336","author":"Kumar","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118205_bib62","article-title":"Synthesis and anticancer evaluation of benzylated indole based Alkyl\u2010Substituted Pyrido [2, 3\u2010d] pyrimidines targeting thymidylate synthase","volume":"9","author":"Kumar","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2025.118205_bib63","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2147\/IJN.S150237","article-title":"Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer","author":"Bai","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejmech.2025.118205_bib64","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.118205_bib65","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.24963","article-title":"Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library","volume":"9","author":"Kobayashi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.118205_bib66","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1038\/s41467-021-22801-0","article-title":"Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer","volume":"12","author":"Wu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118205_bib67","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1021\/acsmedchemlett.4c00389","article-title":"1-Deoxynojirimycin derivative containing tegafur induced HCT-116 cell apoptosis through mitochondrial dysfunction and oxidative stress pathway","volume":"15","author":"Tang","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118205_bib68","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1111\/jcmm.17799","article-title":"Pemetrexed induces ROS generation and cellular senescence by attenuating TS\u2010mediated thymidylate metabolism to reverse gefitinib resistance in NSCLC","volume":"27","author":"Chen","year":"2023","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejmech.2025.118205_bib69","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2174\/187152008783961914","article-title":"Caspase activity modulators as anticancer agents","volume":"8","author":"Okun","year":"2008","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib70","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.biochem.73.011303.073706","article-title":"Cytochrome C-mediated apoptosis","volume":"73","author":"Jiang","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2025.118205_bib71","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nm1263","article-title":"Caspase-independent cell death","volume":"11","author":"Kroemer","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2025.118205_bib72","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2174\/092986707781745569","article-title":"Apoptosis: potential therapeutic targets for new drug discovery","volume":"14","author":"Jana","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib73","first-page":"5934","article-title":"Effects of glycyrrhizin on cell proliferation and apoptosis in MCF-7 human breast cancer cells","volume":"14","author":"Wang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejmech.2025.118205_bib74","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejmech.2025.118205_bib75","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","article-title":"A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V","volume":"184","author":"Vermes","year":"1995","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejmech.2025.118205_bib76","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/nprot.2006.238","article-title":"Analysis of apoptosis by propidium iodide staining and flow cytometry","volume":"1","author":"Riccardi","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2025.118205_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph1208s25","article-title":"Measurement of cell death in mammalian cells","volume":"25","author":"Cummings","year":"2004","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118205_bib78","series-title":"Advanced Protocols in Oxidative Stress II","first-page":"57","article-title":"Identification of ROS using oxidized DCFDA and flow-cytometry","author":"Eruslanov","year":"2009"},{"key":"10.1016\/j.ejmech.2025.118205_bib79","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118205_bib80","first-page":"301","article-title":"Tyrosine hydroxylase expression in a catecholaminergic cell line detected by immunofluorescence","volume":"29","author":"Crawford","year":"1992","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejmech.2025.118205_bib81","first-page":"665","article-title":"Wound healing: a cellular perspective","volume":"89","author":"Rodrigues","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2025.118205_bib82","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/bit.10655","article-title":"Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types","volume":"83","author":"Kelm","year":"2003","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.ejmech.2025.118205_bib83","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nprot.2008.226","article-title":"Spheroid-based drug screen: considerations and practical approach","volume":"4","author":"Friedrich","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2025.118205_bib84","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1089\/adt.2015.655","article-title":"High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures","volume":"13","author":"Sirenko","year":"2015","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.ejmech.2025.118205_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138301","article-title":"Combined computational and synthetic strategies for the development of potent pyrazolo-pyridine derivatives as anticancer agents","volume":"1311","author":"Ayaz","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118205_bib86","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1007\/s00044-014-0996-y","article-title":"Anti-asthmatic activity of azepino [2, 1-b] quinazolones, synthetic analogues of vasicine, an alkaloid from Adhatoda vasica","volume":"23","author":"Rayees","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.118205_bib87","article-title":"Design and Efficient synthesis of new 4-Amino-Substituted 2-(4-Bromobenzyl)-5, 6, 7, 8-tetrahydrobenzo [4, 5] thieno [2, 3-d] pyrimidines of anticancer interest and their in silico study","author":"Arora","year":"2024","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2025.118205_bib88","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13065-024-01228-w","article-title":"Synthesis and anticancer evaluation of diaryl pyrido [2, 3-d] pyrimidine\/alkyl substituted pyrido [2, 3-d] pyrimidine derivatives as thymidylate synthase inhibitors","volume":"18","author":"Kumar","year":"2024","journal-title":"BMC Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib89","doi-asserted-by":"crossref","first-page":"12668","DOI":"10.1080\/07391102.2023.2175265","article-title":"Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17\u03b2-hydroxysteroid dehydrogenase type 5 (17\u03b2-HSD5) inhibitors","volume":"41","author":"Kulkarni","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2025.118205_bib90","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2174\/2589977511666190912154817","article-title":"In-silico design, ADMET screening, MM-GBSA binding free energy of some novel isoxazole substituted 9-anilinoacridines as HER2 inhibitors targeting breast cancer","volume":"11","author":"Kalirajan","year":"2019","journal-title":"Curr. Drug Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118205_bib91","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1039\/D4MD00199K","article-title":"Thiazolidine-2, 4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis, in vitro and in vivo anti-diabetic evaluation","volume":"15","author":"Singh","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib92","first-page":"gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.118205_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900029","article-title":"Design, synthesis, biological evaluation, and molecular modeling studies of rhodanine derivatives as pancreatic lipase inhibitors","volume":"352","author":"Chauhan","year":"2019","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.118205_bib94","first-page":"6284","article-title":"Synthesis, characterization, theoretical studies and in vitro embriyotoxic, genotoxic and anticancer effects of novel phenyl (1, 4, 6-Triphenyl-2-Thioxo-1, 2, 3, 4-Tetrahydropyrimidin-5-yl) methanone, polycyclic aromat","volume":"44","author":"Akbas","year":"2024","journal-title":"Compd"},{"key":"10.1016\/j.ejmech.2025.118205_bib95","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2174\/1568026615666150825142726","article-title":"Computational sampling and simulation based assessment of novel Mycobacterium tuberculosis glutamine synthetase inhibitors: study involving structure based drug design and free energy perturbation","volume":"16","author":"Suryadevara","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118205_bib96","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202400322","article-title":"Identification of novel Thiazolidinedione based pancreatic lipase inhibitors for the management of obesity using in Silico approach","volume":"9","author":"Khator","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2025.118205_bib97","first-page":"1","article-title":"Identification of 1, 3, 4-oxadiazoles as tubulin-targeted anticancer agents: a combined field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, molecular dynamics simulation, and density functional theory calculation approach","author":"Das","year":"2023","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:04:54Z","timestamp":1773147894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425009705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":97,"alternative-id":["S0223523425009705"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118205","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, anticancer evaluation, and In silico studies of 2-thiopyrimidine-5-carbonitrile derivatives as potent thymidylate synthase inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118205"}}